Scientific Dissemination

Fellow Publications: 2008-2015

(Fellows in bold; asterisk (*) denotes current PhD candidates)

1.     Bepe N, Madanhi N, Mudzviti T*, Gavi S, Maponga CC, Morse GD. The impact of herbal remedies on adverse effects and quality of life in HIV-infected individuals on antiretroviral therapy. J Infect Dev Ctries. 2011:5(1):48-53.PMCID: PMC3424263. 2. Fehintola FA, Akinyinka OO, Adewole IF, Maponga CC, Ma Q, Morse GD. Drug Interactions in the Treatment and Chemoprophylaxis of Malaria in HIV infected individuals in Sub Saharan Africa. Curr Drug Metab. 2011: Jan 1;12(1):51-6. PMCID: PMC3233991.

2.     Fehintola FA, Scarsi KK, Ma Q, Parikh S, Morse GD, Taiwo B, Akinola IT, Adewole IF, Lindegardh N, Phakderaj A, Ojengbede O, Murphy RL, Akinyinka OO, and Aweeka FT. Nevirapine-Based Antiretroviral Therapy Impacts Artesunate and Dihydroartemisinin Disposition in HIV-Infected Nigerian Adults. AIDS Research and Treatment 2012: ID 703604, 2012. doi:10.1155/2012/703604 PMCID: PMC3303559.

3.     Mudzviti T*, Maponga CC, Khoza S, Ma Q, and Morse GD. The Impact of Herbal Drug Use on Adverse Drug Reaction Profiles of Patients on Antiretroviral Therapy in Zimbabwe. AIDS Research Treatment 2012: Article ID 434171, 4 pages doi:10.1155/2012/434171 PMC3313558.

4.     Mudzviti T*, Sibanda M, Gavi S, Maponga CC, Morse GD. Implementing a pharmacovigilance program to evaluate cutaneous adverse drug reactions in an antiretroviral access program. J Infect Dev Ctries. 2012 Nov 26;6(11):806-8. doi: 10.3855/jidc.1908.PMC3535441.

5.     Tshabalala M, Manasa J, Zijenah LS, Rusakaniko S, Kadzirange G. Surveillance of Transmitted Antiretroviral Drug Resistance among HIV-1 Infected Women Attending Antenatal Clinics in Chitungwiza, Zimbabwe. PLoS ONE 2011: 6(6): e21241. PMCID: PMC3116901.

6.     Mushonga NGT, Chagwena D, Benhura C, Nyanga LK. An Assessment of the Nutritional Status of University of Zimbabwe Students. Pakistan J Nutrition 2013: 12 (1): 30-33.

7.     Tshabalala M, Morse GD, Zijenah L. HLA Genetic Polymorphisms: Role in HIV-1 Susceptibility, Disease Progression and Treatment Outcomes. Retrovirology: Research and Treatment. 2013:5 1–8 doi: 10.4137/RRT.S11589/Libertas Academica Ltd. 

8.     Mudzviti T*, Maponga C, Khoza S, Ma Q, Tagwireyi D. Clinical Pharmacology in the Emerging Countries: Clinical Toxicities of First-Line Antiretroviral Therapy in a Resource limited Setting. Basic and Clinical Pharmacology Toxicology 2010: 107 (Suppl. 1), p475. 

9.     Dube A, Reynolds JL, Law WC, Prasad PN, Morse GD. Multimodal nanoparticles that provide immunomodulation and intracellular drug delivery for infectious diseases. Nanomedicine 2013: Dec 10. pii: S1549-9634(13)00677-1. doi: 10.1016/j.nano.2013.11.012. [Epub ahead of print]. PMID: 24333593.

10.  Scarsi KK, Fehintola FA, Ma Q, Aweeka FT, Darin KM, Morse GD, Akinola IT, Adedeji WA, Lindegardh N, Tarning J, Ojengbede O, Adewole IF, Taiwo B, Murphy RL, Akinyinka OO, Parikh S. Disposition of amodiaquine and desethylamodiaquine in HIV-infected Nigerian subjects on nevirapine-containing antiretroviral therapy. J Antimicrob Chemother. 2014 May;69(5):1370-6. PMCID: PMC3977609

11.   Mushonga NGT, Kujinga P, Chagwena DT, Chituwu R and Nyabanga G. Retrospective Study of the Nutritional Status of Primary School Children in Harare. African Journal of Food, Agriculture, Nutrition and Development. 2014 May; 14(3): 8837-47.

12.   Chopera P, Chagwena DT, Mushonga NGT. Food label reading and understanding in parts of rural and urban Zimbabwe. African Health Sciences. 2014 Sep;14(3):576-84. PMCID: PMC4209636

13.   Mudzviti, T*., Mudzongo, N.T., Gavi, S., Chimbetete, C., Maponga, C.C. and Morse, G.D. (2015) A Time to Event Analysis of Adverse Drug Reactions Due to Tenofovir, Zidovudine and Stavudine in a Cohort of Patients Receiving  Antiretroviral Treatment at an Outpatient Clinic in Zimbabwe. Pharmacology & Pharmacy, 6, 201-206.http://dx.doi.org/10.4236/pp.2015.

14.   Mudzengi J, Monera TG*, Nhachi CHB. Microbial and heavy metal quality of selected herbal medicines commonly used by HIV patients in Zimbabwe. Journal of Applied Science in Southern Africa. 2013. Vol 19i: 28-42.

15.   Bhunu CP, Mushayabasa S,  Monera TG*. Assessing the Impact of Vaccination on Controlling the Spread of Human Scabies.  ISRN Computational Biology, vol. 2013, Article ID 362973, 7 pages, 2013. doi:10.1155/2013/362973.

16.   Tapfumaneyi P, Monera TG*. Lifestyle Interventions for Cancer Health Promotion: Assessing Attitudes, Perceptions and Awareness Among Community Pharmacist in Harare. Pharmaceutical Journal of Zimbabwe Vol.5, Issue 1 ,February 2013

17.   Mureyi DD, Monera TG*, Maponga CC. Prevalence and patterns of prenatal use of traditional medicine among women at selected Harare clinics: a cross-sectional study. BMC Complement Altern Med 12 (1): 164 (2012) PMID 23016608

18.   Monera TG*, Maponga CC.  Prevalence and patterns of Moringa oleifera use among HIV positive patients in Zimbabwe: a cross-sectional survey.  Journal of Public Health in Africa Vol3, No 1 2012-10-24

19.   Monera TG*.  The Pharmacists Role in Clinical Trials. Pharmaceutical Journal of Zimbabwe Vol.2, Issue 2, September 2009

20.   Monera TG*, Wolfe AR, Maponga CC, Benet LZ, Guglielmo J.  Moringa oleifera leaf extract inhibit 6beta-hydroxylation of testosterone by CYP3A4.  J Infect Dev Ctries 2(5): 379 – 83 (2008) PMID 19745507.